MedWatch

Amplifon expands Chinese presence in new joint venture

A novel Chinese collaboration increases the presence of hearing aid company Amplifon in the market in Southeast China.

Photo: Jens Dresling

The Italian retailer Amplifon, which is a customer of both Demant and GN Hearing, has taken a larger chunk of the Chinese retail market.

The firm has started a new joint venture company with a local partner, which Amplifon will own 51 percent of, the Italian firm revealed on Tuesday.

The joint venture will increase Amplifon's presence in the Zheijang province and Southeast China.

"This transaction represents another important step in our journey to build a leading position in the strategic Chinese market, which represents a sizeable medium-term opportunity given the estimated market size and its outstanding growth potential," says CEO Enrico Vita in a press release.

The transaction has already received all the regulatory clearances that are necessary from local authorities, according to Amplifon.

The Italian company is the world's largest retailer of hearing aids with a global market share of around 11 percent.

It has shops in 26 countries and around 9,000 audiologists in its employ.

FDA plans new sales channel for hearing aids in autumn 

Sale of hearing aids in the US exceeds 4 million devices for the first time 

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs